Yep the weak buy side is keeping me out. I'll just keep watching for now. Even if I miss the initial run given lack of interest I'm sure there'll be plenty of opportunity to jump in.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025